Paul Hartmann AG Sustainability Profile
Paul Hartmann AG, commonly referred to as Hartmann, is a leading player in the healthcare industry, headquartered in Heidenheim, Germany. Founded in 1818, the company has evolved significantly, establishing a strong presence in Europe and beyond, particularly in the fields of wound care, incontinence management, and surgical products. Hartmann is renowned for its innovative medical solutions, including advanced wound dressings and high-quality incontinence products, which are designed to enhance patient comfort and promote healing. The company’s commitment to quality and sustainability sets it apart in a competitive market, earning it a reputation for reliability and excellence. With a rich history and a focus on research and development, Paul Hartmann AG continues to achieve notable milestones, solidifying its position as a trusted partner in healthcare across various regions.
DitchCarbon Score
How does Paul Hartmann AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Paul Hartmann AG's score of 24 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Paul Hartmann AG's reported carbon emissions
In 2024, Paul Hartmann AG reported total emissions of approximately 70.4 million kg CO2e, comprising 30.2 million kg CO2e from Scope 1 and 40.2 million kg CO2e from Scope 2 emissions. This reflects a slight increase from 2023, where total emissions were about 79.3 million kg CO2e, with Scope 1 at 29.2 million kg CO2e and Scope 2 at 50.1 million kg CO2e. Over the past few years, the company has shown a commitment to reducing its carbon footprint, although specific reduction targets or initiatives have not been disclosed. The emissions data indicates that Paul Hartmann AG has not reported any Scope 3 emissions, which typically encompass indirect emissions from the value chain. The company has not set any Science-Based Targets Initiative (SBTi) reduction targets or other formal climate pledges, indicating a potential area for future commitment. Overall, Paul Hartmann AG's emissions data highlights the need for ongoing monitoring and potential strategies to enhance sustainability efforts in line with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 24,077,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 47,504,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - |
How Carbon Intensive is Paul Hartmann AG's Industry?
How Carbon Intensive is Paul Hartmann AG's Location?
Paul Hartmann AG's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Paul Hartmann AG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
B. Braun Melsungen AG
ICU Medical
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.